prostate cancer

Bayer’s Nubeqa scores key prostate cancer win in battle with Pfizer, J&J
Fierce Pharma
Thu, 01/30/20 - 09:15 pm
Bayer
Orion
Nubeqa
prostate cancer
clinical trials
First of its Kind “Universal” Immune Cell Cancer Therapy
Xtalks
Thu, 01/23/20 - 12:18 pm
cancer
immune system
prostate cancer
lung cancer
breast cancer
Cardiff University
Progenics Plans to Seek Approval for Prostate Cancer Imaging Tool Following Phase III Results
BioSpace
Mon, 12/23/19 - 11:48 pm
Progenics Pharmaceuticals
prostate cancer
PyL
cancer imaging
diagnostics
Pfizer, Astellas' Xtandi matches J&J's rival Erleada with new prostate cancer nod
Fierce Pharma
Mon, 12/16/19 - 10:37 pm
Pfizer
Astellas
Xtandi
prostate cancer
JNJ
Erleada
FDA
Turning Merck's COPD drug against resistant prostate cancer
Fierce Biotech
Wed, 12/4/19 - 11:22 pm
Merck
prostate cancer
navarixin
Is Myovant's New Prostate Cancer Drug a Game Changer?
Motley Fool
Tue, 11/26/19 - 10:33 am
Myovant Sciences
prostate cancer
clinical trials
Relugolix
Myovant to submit lead drug for prostate cancer approval after Phase 3 results
Biopharma Dive
Tue, 11/19/19 - 10:12 am
Myovant Sciences
prostate cancer
clinical trials
Relugolix
Bone Tumors Stop Immunotherapy Working For Prostate Cancer
Forbes
Sun, 11/17/19 - 08:53 pm
immunotherapy
prostate cancer
bone tumors
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
Xconomy
Tue, 10/1/19 - 10:29 am
ESMO
PARP inhibitors
prostate cancer
KRAS
Seattle Genetics
AstraZeneca
Merck
GSK
Amgen
breast cancer
Roche
Pfizer
Updated Erleada Data Shows Reduced Risk of Death in Prostate Cancer Patients
BioSpace
Sat, 09/28/19 - 04:25 pm
Erleada
Janssen
JNJ
ESMO
prostate cancer
Treating resistant prostate cancer by depriving a key hormone of its 'co-pilot'
Fierce Biotech
Thu, 08/29/19 - 12:22 pm
prostate cancer
metastatic castration-resistant prostate cancer
Carrick
C&7001
Pfizer, Astellas rocket toward broader Xtandi use with FDA 'priority' tag
Fierce Pharma
Thu, 08/22/19 - 11:56 am
Pfizer
Astellas
Xtandi
prostate cancer
FDA
priority review
AstraZeneca Success On Prostate Cancer Drug Lowers Enthusiasm For Clovis
Yahoo/Benzinga
Wed, 08/14/19 - 10:13 am
AstraZeneca
Clovis Oncology
prostate cancer
Lynparza
Clovis investors feel more Lynparza pressure
EP Vantage
Thu, 08/8/19 - 10:51 am
prostate cancer
Lynparza
Rubraca
Clovis Oncology
AstraZeneca
Merck
AstraZeneca, Merck herald PhIII prostate cancer win for Lynparza — overtaking Clovis, J&J in PARP race
Endpoints
Wed, 08/7/19 - 10:46 am
Lynparza
AstraZeenca
Merck
prostate cancer
clinical trials
Bayer's Prostate Cancer Drug Earns FDA Approval
BioSpace
Thu, 08/1/19 - 10:22 am
Bayer
Nubeqa
darolutamide
prostate cancer
Bayer, Orion win speedy approval for prostate cancer drug darolutamide
Endpoints
Wed, 07/31/19 - 08:51 am
Bayer
Orion
prostate cancer
darolutamide
FDA
Did cancer clinical trials stay on track at ASCO 2019?
Pharmaforum
Fri, 07/19/19 - 01:00 pm
ASCO
clinical trials
cancer
ASCO 2019
bladder cancer
breast cancer
prostate cancer
pancreatic cancer
Dementia tied to hormone-blocking prostate cancer treatment
Yahoo/AP
Sun, 07/7/19 - 10:25 pm
Alzheimer's disease
prostate cancer
Spotlight on: Exosome Diagnostics, first to develop RNA-based liquid biopsies
CP Wire
Wed, 06/5/19 - 07:28 pm
Exosome Diagnostics
diagnostics
Bio-Techne
prostate cancer
lung cancer
RNA

Pages